India to Panama Pharmaceutical Export (2026) — $26.4M, 166 Suppliers | TransData Nexus

India to Panama Pharmaceutical Export (2026) — $26.4M, 166 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Panama

#	Formulation	Value	Share
1	Omapin C-20 (each Hard Gelatin Capsule Conts:omeprazole USP 20mg) B.no.bnc11230…	$2.1M	8.0%
2	Paziglip 10mg 30fct Cac Material No. - 44116240	$1.3M	4.8%
3	Tenofovir Disoproxil Fumarate 300mg+ Emtricitabine 200mg Tablets 30s- Cartonles…	$1.1M	4.0%
4	Pharma Drug&med: Ach - Paricalcitol Accord 5mcg/ml,1ml,5v(ac-pa Each ML Contain…	$402.2K	1.5%
5	Caspofungin Powder for Concentrate for Solution for Infusion 50mg/vial,10ml (ly…	$344.7K	1.3%
6	Other- Lorvas Sr Tablet Size 3 X 10 Tablets	$330.7K	1.3%
7	Caspofungin Powder for Concentrate for Solution for Infusion 50mg/vial10ml (lyo…	$299.4K	1.1%
8	Metaspray Nasal Spray Pack Size:1 X 140 Md	$272.5K	1.0%
9	Mycophenolate Mofet 250mg 50hgc Pa Material No. - 993122	$266.3K	1.0%
10	Caspofungin Powder for Concentrate for Solution for Infusion 50mg/vial, 10ml(ly…	$265.2K	1.0%
11	Lorvas Sr Tablet ( =3x10 Tablets)	$240.6K	0.9%
12	Pharmaceutical Product Vitacox 120mg Tablets Vitacox 120mg (2 X 7t) Rm:etoricox…	$193.1K	0.7%
13	Amoxicillin Capsules BP 500mg -amoxapen	$190.5K	0.7%
14	Low Molecular Weight Heparin Enoxaparinsodium Injection Usp,80mg in 0.8ml Pre-f…	$176.3K	0.7%
15	H.l.medicine for Human B.n. Pt0701624-2724 M.dt. 12/2024 E. Dt. 11/2027 Perindo…	$163.5K	0.6%

India exports 20+ pharmaceutical formulations to Panama with a combined trade value of $26.4M. Key products include Tenofovir ($1.1M), Mycophenolate ($266K), Amoxicillin ($191K), Raltegravir ($155K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 5,872 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Panama Trade Routes

1Tenofovir$1.1M

2Mycophenolate$266K

3Amoxicillin$191K

4Raltegravir$155K

These are the top pharmaceutical products exported from India to Panama, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Panama buyers, regulatory requirements, and logistics for that specific product corridor. Products include Tenofovir ($1.1M), Mycophenolate ($266K), Amoxicillin ($191K), — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Panama

1Sandoz Private Limited

$2.9M

2Brawn Laboratories Limited

$2.6M

3Mylan Laboratories Limited

$1.3M

4Torrent Pharmaceuticals Ltd

$1.1M

5Gland Pharma Ltd

Port Analysis — India to Panama Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)7.5%

SAHAR AIR23.6%

SAHAR AIR CARGO ACC (INBOM4)30.3%

MUNDRA SEA0.1%

DELHI AIR2.9%

Panama Import Ports

PANAMA CITY -70.2%

Manzanillo3.5%

Colon0.3%

PANAMA CITY14.7%

Balboa0.6%

Trade Statistics

Total Value$26.4M

Shipments5,872

Indian Exporters166

Panama Buyers329

Avg Shipment$4K

Products3,619

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Panama Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The India-Panama pharmaceutical trade corridor has experienced significant growth over the past decade. In 2014, India's pharmaceutical exports to Panama were valued at $8.99 million, which increased to $13.88 million by 2018, marking a 54.39% growth during this period. This upward trajectory continued, with total exports reaching $26.4 million by 2026, encompassing 5,872 shipments from 166 Indian exporters to 329 Panamanian buyers. The average shipment value stood at $4,000, indicating a diverse range of products and transaction sizes.

Key milestones in this evolution include the establishment of the Colón Free Trade Zone, which has attracted multinational corporations to import, package, and re-export pharmaceutical products, thereby enhancing Panama's role as a regional distribution hub. Additionally, India's reputation as the "pharmacy of the world," supplying around one-fifth of global demand for generic medicines, has bolstered its position in the Panamanian market.

2India's Market Position

India holds a significant position in Panama's pharmaceutical import landscape. In 2024, India's pharmaceutical exports to Panama were valued at $21.39 million, accounting for approximately 7.9% of Panama's total pharmaceutical imports, which stood at $269.01 million. This positions India as a key supplier, second only to the United States, which accounted for 35% of India's pharmaceutical exports in 2022.

The strategic importance of this trade is underscored by Panama's role as a regional distribution hub, facilitated by its connectivity and favorable fiscal regime. India's competitive edge lies in its ability to provide a wide array of generic medicines, catering to Panama's diverse healthcare needs.

Panama Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to export products to Panama must navigate a structured registration process overseen by Panama's Ministry of Health (MINSA). The registration dossier should adhere to the Common Technical Document (CTD) format, encompassing comprehensive data on product composition, manufacturing processes, and quality control measures. Bioequivalence studies are mandatory for generic products to demonstrate therapeutic equivalence to the reference listed drug. The registration timeline typically spans 6 to 12 months, contingent upon the completeness of the submitted documentation and the efficiency of the regulatory review process.

It's noteworthy that Panama does not impose pharmaceutical price regulations, and the Colón Free Trade Zone offers 100% import duty exemptions on pharmaceutical medicines. This favorable regulatory environment enhances the attractiveness of the Panamanian market for Indian exporters.

2GMP & Facility Requirements

Panama mandates that pharmaceutical products imported into the country be manufactured in facilities compliant with Good Manufacturing Practices (GMP) as per World Health Organization (WHO) standards. Indian manufacturers must ensure that their production sites meet these stringent requirements, which encompass quality management systems, personnel qualifications, sanitation, and equipment maintenance. The inspection process involves a thorough evaluation of the manufacturing facility by Panamanian health authorities or their designated representatives. While Panama recognizes WHO-GMP certifications, Indian manufacturers should be prepared for potential inspections to verify compliance.

The mutual recognition of GMP standards between India and Panama facilitates smoother trade relations, as Indian manufacturers are already accustomed to adhering to internationally recognized quality standards.

3Import Documentation

To import pharmaceutical products into Panama, Indian exporters must provide several key documents:

Certificate of Pharmaceutical Product (CPP): Issued by the Central Drugs Standard Control Organisation (CDSCO) in India, this certificate attests to the product's compliance with Indian regulations and its market authorization status.

Certificate of Analysis (CoA): A document from the manufacturer detailing the product's quality control testing results, ensuring that the product meets specified standards.

GMP Certificate: A declaration confirming that the manufacturing facility adheres to GMP standards, preferably recognized by WHO.

Customs procedures for pharmaceutical imports into Panama involve the submission of these documents to the National Customs Authority, along with a commercial invoice and a bill of lading. The Colón Free Trade Zone's status as a duty-free area simplifies the import process, reducing the administrative burden on exporters.

TransData Nexus Research · Panama regulatory databasesMar 2026

FAQ — India to Panama Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Panama?

India exported pharmaceuticals worth $26.4M to Panama across 5,872 verified shipments.

Who are the top Indian pharmaceutical exporters to Panama?

1. SANDOZ PRIVATE LIMITED — $2.9M. 2. BRAWN LABORATORIES LIMITED — $2.6M. 3. MYLAN LABORATORIES LIMITED — $1.3M. Total: 166 suppliers.

Which companies in Panama import pharmaceuticals from India?

1. DIMEDICFARM INC — $2.1M. 2. SANDOZ PHARMACEUTICALS PANAMA, S.A — $1.9M. 3. MINISTERIO DE SALUD — $1.5M. 329 buyers total.

What pharmaceutical products does India export most to Panama?

1. Omapin C-20 (each Hard Gelatin Capsule Conts:omeprazole USP 20mg) B.no.bnc11230… ($2.1M, 8.0%); 2. Paziglip 10mg 30fct Cac Material No. - 44116240 ($1.3M, 4.8%); 3. Tenofovir Disoproxil Fumarate 300mg+ Emtricitabine 200mg Tablets 30s- Cartonles… ($1.1M, 4.0%); 4. Pharma Drug&med: Ach - Paricalcitol Accord 5mcg/ml,1ml,5v(ac-pa Each ML Contain… ($402.2K, 1.5%); 5. Caspofungin Powder for Concentrate for Solution for Infusion 50mg/vial,10ml (ly… ($344.7K, 1.3%)

Which ports handle pharmaceutical shipments from India to Panama?

Export: NHAVA SHEVA SEA (INNSA1), SAHAR AIR, SAHAR AIR CARGO ACC (INBOM4), MUNDRA SEA, DELHI AIR. Import: PANAMA CITY -, Manzanillo, Colon, PANAMA CITY, Balboa.

Why does Panama import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $26.4M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Panama?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Panama pharmaceutical trade?

$4.5K per consignment across 5,872 shipments.

How many Indian pharmaceutical companies export to Panama?

166 Indian companies. Largest: SANDOZ PRIVATE LIMITED with $2.9M.

How can I find verified Indian pharmaceutical suppliers for Panama?

TransData Nexus covers 166 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Panama identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 5,872 verified shipments from 166 Indian exporters to 329 Panama buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

166 Exporters

329 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Panama Pharmaceutical Export

Top Pharmaceutical Formulations — India to Panama

Top Pharmaceutical Products — India to Panama Trade Routes

Top Indian Exporters to Panama

Port Analysis — India to Panama Pharmaceutical Shipments

Indian Export Ports

Panama Import Ports

Trade Statistics

Other Destinations

India–Panama Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

Top Panama Buyers from India

Product Routes

Full Dataset Access

3Recent Developments

Panama Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Panama

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Panama

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Panama Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance